Country Pharmaceutical Situation on Access, Quality, and Rational Use of Medicines: An Evidence from a middle-income country

Document Type : Research article

Authors

1 Department. of Pharmacoeconomics and Pharma Management, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

2 Department of Pharmacoeconomics and Pharma Management, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

3 Health Policy Research Center, Institute of Health, Shiraz University of Medical Science, Shiraz, IR Iran.

4 Department of Pharmacoeconomics and Pharma management, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Abstract

Introduction: Evaluation of pharmaceutical systems performance is an essential prerequisite for promoting evidence-based policy-making, improvement in health system performance. This study attempts to evaluate the performance of Iran pharmaceutical system based on the world health organization (WHO)'s indicators, including access, quality, and rational use of medicines.
Methods: In this cross-sectional descriptive study, inspired by the instructions proposed by WHO, public and private pharmaceutical service-providers were evaluated in three dimensions and 16 indicators. Accordingly, eleven separate checklists were developed and, in terms of translation, face and content validity were certified by pharmaceutical sector’s experts. Sampling was randomly carried out in five cities. Depending on the type of indicators, retrospective or prospective approaches was determined for data collection. The data were collected from April to November 2018 and analyzed by SPSS 24.
Results: The availability of targeted key medicines in various cities as well as in public and private pharmacies was 97.5% with no significant difference. Although the medicines cost was higher in private sectors than in public ones, they were affordable in both sectors. In quality indicators, public sectors enjoyed a higher level than the private sectors did. The average number of medicines per prescription in public pharmacies was 3.2 and it was 3.4 in private ones. On average, in public sectors 33% and 32% of outpatients received antibiotics and injectable medicines, respectively. Finally, 77% of medicines were prescribed by using their generic names and 25% of prescriptions were in accordance with key medicines list.

Keywords

Main Subjects


(1)
(2)
(3)
(4)
Buse K, Mays N and Walt G. Making health policy.
McGraw-Hill Education (UK) (2012). 1:1-10.
Lu Y, Hernandez P, Abegunde D and Edejer T. The
world medicines situation 2011. Geneva: Medicine
expenditures World Health Organization (2011) 35-8.
Hogerzeil HV. Essential medicines and human rights:
what can they learn from each other? Bull. World
Health Organ. (2006) 84: 371–5.
WHO Medicines strategy 2004-2007: countries at the
core. World Health Organization (2004). 13-6. 
Iran Pharmaceutical Situation on Access, Quality, and Rational Use of Medicines
2203
Naffa S. Pharmaceutical Situation Assessment in
Jordan (level II) (2012) 1-57.
Saeed A, Saeed H, Saleem Z, Fang Y and Babar Z-UD. Evaluation of prices, availability and affordability
of essential medicines in Lahore Division, Pakistan: A
cross-sectional survey using WHO/HAI methodology.
PLoS One (2019) 14:1-16.
Younis NA-M. Medicine prices, availability,
affordability and price components in United Arab
Emirates. (2006) 1-6.
Helfer AP, Camargo AL, Tavares NUL, Kanavos P
and Bertoldi AD. Affordability and availability of
drugs for treatment of chronic diseases in the public
health care system. Pan American Journal of Public
Health. (2012). 31:1-5.
Alefan Q, Amairi R and Tawalbeh S. Availability,
prices and affordability of selected essential medicines
in Jordan: a national survey. BMC Health Serv. Res.
(2018) 18:787.
Jaffar SA. Medicine prices, availability, affordability
and price components in Oman. (2007) 1-6.
Xi X, Chen P, Yang F, Yang Y, Chen L and Mao N.
Evaluating the accessibility of essential medicines in
China. J. Med. Econ. (2018) 784–92.
Thawani V. Rational use of medicines: Achievements
and challenges. Indian J. Pharmacol. (2010) 42: 63-4.
How to investigate drug use in health facilities:
selected drug use indicators. (1993) 1-5.
Meskarpour-Amiri M, Dopeykar N, Mehdizadeh P,
Ayoubian A and Motaghed Z. A Study on the Factors
Affecting the Prescription of Injection Medicines in
Iran: A Policy Making Approach. Glob. J. Health Sci.
(2015) 7: 291-7.
Karimi A, Haerizadeh M, Soleymani F, Haerizadeh
M and Taheri F. Evaluation of medicine prescription
pattern using World Health Organization prescribing
indicators in Iran: A cross-sectional study. J. Res.
Pharm. Pract. (2014) 3: 39-45.
Awad A and Al-Saffar N. Evaluation of drug use
practices at primary healthcare centers of Kuwait. Eur.
J. Clin. Pharmacol. (2010) 66: 1247-55.
Parveen Z, Gupta S, Kumar D and Hussain S. Drug
utilization pattern using WHO prescribing, patient
care and health facility indicators in a primary and
secondary health care facility. Natl. J. Physiol. Pharm.
Pharmacol. (2016) 6: 182-90.
Mahmood A, Elnour AA, Ali AAA, Hassan NAGM,
Shehab A and Bhagavathula AS. Evaluation of rational
use of medicines (RUM) in four government hospitals
in UAE. Saudi Pharm. J. (2016) 24: 189-96.
El Mahalli AA. WHO/INRUD drug prescribing
indicators at primary health care centres in Eastern
province, Saudi Arabia. East. Mediterr. Heal. J. (2012)
18: 1091-6.
Lima MG, Álvares J, Guerra Junior AA, Costa EA,
Guibu IA and Soeiro OM. Indicators related to the
rational use of medicines and its associated factors.
Rev. Saude Publica (2017) 51: 1-8.
Dong L, Yan H and Wang D. Drug prescribing
indicators in village health clinics across 10 provinces
of Western China. Fam. Pract. (2011) 28: 63-7.
Lima MG, Dutra KR and Martins UCM. Prescribing
indicators in primary health care in Belo Horizonte,
Brazil: associated factors. Int. J. Clin. Pharm. (2017)
39: 913-8.
Yousefi N, Rashidian A, Soleymani F and
Kebriaeezade A. Relationship between the provision
of injection services in ambulatory physician offices
and prescribing injectable medicines. Iran. J. Pharm.
Res. (2017) 16: 399-405.
Sadeghian G-H, Safaeian L, Mahdanian A-R, Salami S
and Kebriaee-Zadeh J. Prescribing quality in medical
specialists in Isfahan, Iran. Iran. J. Pharm. Res. (2013)
12: 235-42
Holloway KA, Ivanovska V, Wagner AK, VialleValentin C and Ross-Degnan D. Have we improved use
of medicines in developing and transitional countries
and do we know how to? Two decades of evidence.
Trop. Med. Int. Heal. (2013) 18: 656-64.
Sharif SI, Al-Shaqra M, Hajjar H, Shamout A and
Wess L. Patterns of drug prescribing in a hospital in
Dubai, United Arab Emirates. Libyan J. Med. (2009)
3: 10-2.